These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11212671)
1. [MHC class I deficiency]. Morio T Ryoikibetsu Shokogun Shirizu; 2000; (32):15-7. PubMed ID: 11212671 [No Abstract] [Full Text] [Related]
2. P-glycoprotein plays an insignificant role in the presentation of antigenic peptides to CD8+ T cells. Russ G; Ramachandra M; Hrycyna CA; Gottesman MM; Pastan I; Bennink JR; Yewdell JW Cancer Res; 1998 Oct; 58(20):4688-93. PubMed ID: 9788623 [TBL] [Abstract][Full Text] [Related]
3. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. Leone P; Shin EC; Perosa F; Vacca A; Dammacco F; Racanelli V J Natl Cancer Inst; 2013 Aug; 105(16):1172-87. PubMed ID: 23852952 [TBL] [Abstract][Full Text] [Related]
4. Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome. Furukawa H; Murata S; Yabe T; Shimbara N; Keicho N; Kashiwase K; Watanabe K; Ishikawa Y; Akaza T; Tadokoro K; Tohma S; Inoue T; Tokunaga K; Yamamoto K; Tanaka K; Juji T J Clin Invest; 1999 Mar; 103(5):755-8. PubMed ID: 10074494 [TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis: are HLA class I molecules involved in disease pathogenesis? Martin R; McFarland HF Ann Neurol; 1995 Aug; 38(2):137-9. PubMed ID: 7654058 [No Abstract] [Full Text] [Related]
6. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures. Shi Y; Smith KD; Lutz CT J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533 [TBL] [Abstract][Full Text] [Related]
7. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Abele R; Tampé R Physiology (Bethesda); 2004 Aug; 19():216-24. PubMed ID: 15304636 [TBL] [Abstract][Full Text] [Related]
8. Tapping into tumours. Elliott T Nat Genet; 1996 Jun; 13(2):139-40. PubMed ID: 8640213 [No Abstract] [Full Text] [Related]
9. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells. Boyle LH; Goodall JC; Gaston JS Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184 [TBL] [Abstract][Full Text] [Related]
10. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors. Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421 [TBL] [Abstract][Full Text] [Related]
11. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489 [TBL] [Abstract][Full Text] [Related]
12. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. Neisig A; Roelse J; Sijts AJ; Ossendorp F; Feltkamp MC; Kast WM; Melief CJ; Neefjes JJ J Immunol; 1995 Feb; 154(3):1273-9. PubMed ID: 7822796 [TBL] [Abstract][Full Text] [Related]
13. The peptide-loading complex--antigen translocation and MHC class I loading. Schölz C; Tampé R Biol Chem; 2009 Aug; 390(8):783-94. PubMed ID: 19426129 [TBL] [Abstract][Full Text] [Related]
14. Transporter associated with antigen processing. Elliott T Adv Immunol; 1997; 65():47-109. PubMed ID: 9238508 [No Abstract] [Full Text] [Related]
15. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells. Wang F; Li X; Annis B; Faustman DL Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413 [TBL] [Abstract][Full Text] [Related]
16. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells. Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379 [TBL] [Abstract][Full Text] [Related]
17. Immunology: professional secrets. Roy CR Nature; 2003 Sep; 425(6956):351-2. PubMed ID: 14508466 [No Abstract] [Full Text] [Related]
18. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Hung CF; Cheng WF; He L; Ling M; Juang J; Lin CT; Wu TC Cancer Res; 2003 May; 63(10):2393-8. PubMed ID: 12750257 [TBL] [Abstract][Full Text] [Related]
19. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells. Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095 [TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex-encoded ABC transporters and rat class I peptide motifs. Powis SJ; Young LL; Barker PJ; Richardson L; Howard JC; Butcher GW Transplant Proc; 1993 Oct; 25(5):2752-3. PubMed ID: 8212225 [No Abstract] [Full Text] [Related] [Next] [New Search]